$7.46
+0.39 (+5.52%)
Open$7.08
Previous Close$7.07
Day High$7.70
Day Low$6.70
52W High$15.30
52W Low$5.29
Volume—
Avg Volume14.3K
Market Cap1.01B
P/E Ratio266.42
EPS$0.19
SectorN/A
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 298.44M | 264.43M | 276.45M |
| Net Income | 14.60M | 11.79M | 12.18M |
| Profit Margin | 4.9% | 4.5% | 4.4% |
| EBITDA | 27.42M | 22.09M | 25.58M |
| Free Cash Flow | 13.07M | 10.26M | 10.73M |
| Rev Growth | -8.4% | +2.2% | +6.3% |
| Debt/Equity | 0.81 | 0.83 | 0.74 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.03 | +34.07% | — | 1.41B |
| PICS | Pics Nv | $11.42 | +0.09% | 6.6 | 1.48B |
| DMII | Drugs Made In America Acquis | $10.13 | +0.10% | 75.2 | 645.28M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.75 | +0.55% | 35.5 | 336.67M |
| CEPF | Cantor Equity Partners-Cl A | $10.42 | +0.00% | 57.9 | 595.50M |